Can 23andMe Survive Its Financial Crisis?
Do you remember when 23andMe was the golden child of genetic testing? Millions swabbed their cheeks, eager to uncover ancestry secrets or health risks—until the hype faded, lawsuits piled up, and the company’s stock plummeted. Now, bankruptcy looms. If you’re a shareholder, you might be staring...